Click here to get full coverage on RBC Capital lowers Exelixis (EXEL) price target to $43 - MSN

RBC Capital lowers Exelixis (EXEL) price target to $43  MSN

RBC Capital lowers Exelixis (EXEL) price target to $43 - MSN

Click here to get full coverage on Exel Composites Reduces Shares Quantity, Changes ISIN and Trading Code - TradingView

Exel Composites Reduces Shares Quantity, Changes ISIN and Trading Code  TradingView

Exel Composites Reduces Shares Quantity, Changes ISIN and Trading Code - TradingView

Click here to get full coverage on EXEL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

EXEL Financials: Income Statement, Balance Sheet & Cash Flow  Stock Titan

EXEL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Click here to get full coverage on Exel Composites reduces shares quantity, changes ISIN and trading code - marketscreener.com

Exel Composites reduces shares quantity, changes ISIN and trading code  marketscreener.com

Exel Composites reduces shares quantity, changes ISIN and trading code - marketscreener.com

Click here to get full coverage on Nick Van Exel says Jerrod Calhoun will be great as UC Bearcats' coach - Cincinnati Enquirer

Nick Van Exel says Jerrod Calhoun will be great as UC Bearcats' coach  Cincinnati Enquirer

Nick Van Exel says Jerrod Calhoun will be great as UC Bearcats' coach - Cincinnati Enquirer

Click here to get full coverage on EXEL Stock Price, Quote & Chart | EXELIXIS INC (NASDAQ:EXEL) - ChartMill

EXEL Stock Price, Quote & Chart | EXELIXIS INC (NASDAQ:EXEL)  ChartMill

EXEL Stock Price, Quote & Chart | EXELIXIS INC (NASDAQ:EXEL) - ChartMill

Click here to get full coverage on EXEL: Former Executive Joins Recursion Pharmaceuticals as New CM - GuruFocus

EXEL: Former Executive Joins Recursion Pharmaceuticals as New CM  GuruFocus

EXEL: Former Executive Joins Recursion Pharmaceuticals as New CM - GuruFocus

Click here to get full coverage on Exelixis (EXEL) Down 2.8% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Exelixis (EXEL) Down 2.8% Since Last Earnings Report: Can It Rebound?  Yahoo Finance

Exelixis (EXEL) Down 2.8% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Click here to get full coverage on Nancy Few-Exel - Legacy

Nancy Few-Exel - Legacy

Click here to get full coverage on Insider Sale: EVP of $EXEL Sells 47,918 Shares | EXEL Stock News - Quiver Quantitative

Insider Sale: EVP of $EXEL Sells 47,918 Shares | EXEL Stock News  Quiver Quantitative

Insider Sale: EVP of $EXEL Sells 47,918 Shares | EXEL Stock News - Quiver Quantitative

Click here to get full coverage on How Exelixis’ Earnings Beat and FDA Zanzalintinib Milestone Will Impact Exelixis (EXEL) Investors - simplywall.st

How Exelixis’ Earnings Beat and FDA Zanzalintinib Milestone Will Impact Exelixis (EXEL) Investors  simplywall.st

How Exelixis’ Earnings Beat and FDA Zanzalintinib Milestone Will Impact Exelixis (EXEL) Investors - simplywall.st

Click here to get full coverage on Exel Composites Oyj : Plc has executed a reverse share split - marketscreener.com

Exel Composites Oyj : Plc has executed a reverse share split  marketscreener.com

Exel Composites Oyj : Plc has executed a reverse share split - marketscreener.com

Click here to get full coverage on Vanguard disaggregates holdings; Exelixis (NASDAQ: EXEL) shows 0 shares - Stock Titan

Vanguard disaggregates holdings; Exelixis (NASDAQ: EXEL) shows 0 shares  Stock Titan

Vanguard disaggregates holdings; Exelixis (NASDAQ: EXEL) shows 0 shares - Stock Titan

Click here to get full coverage on EXEL Technical Analysis | Trend, Signals & Chart Patterns | EXELIXIS INC (NASDAQ:EXEL) - ChartMill

EXEL Technical Analysis | Trend, Signals & Chart Patterns | EXELIXIS INC (NASDAQ:EXEL)  ChartMill

EXEL Technical Analysis | Trend, Signals & Chart Patterns | EXELIXIS INC (NASDAQ:EXEL) - ChartMill

Click here to get full coverage on Exelixis (EXEL) Valuation After Earnings Beat FDA Progress And Cabometyx Label Expansion - Yahoo Finance

Exelixis (EXEL) Valuation After Earnings Beat FDA Progress And Cabometyx Label Expansion  Yahoo Finance

Exelixis (EXEL) Valuation After Earnings Beat FDA Progress And Cabometyx Label Expansion - Yahoo Finance

Click here to get full coverage on Exel Composites Oyj : Execution of Exel Composites Plc's reverse share split on 27 march 2026 and change of the company's trading code - marketscreener.com

Exel Composites Oyj : Execution of Exel Composites Plc's reverse share split on 27 march 2026 and change of the company's trading code  marketscreener.com

Exel Composites Oyj : Execution of Exel Composites Plc's reverse share split on 27 march 2026 and change of the company's trading code - marketscreener.com

Click here to get full coverage on Exelixis, Inc. (EXEL) Sees Mixed Analyst Actions as Zanzalintinib Nears Commercial Launch - Yahoo Finance

Exelixis, Inc. (EXEL) Sees Mixed Analyst Actions as Zanzalintinib Nears Commercial Launch  Yahoo Finance

Exelixis, Inc. (EXEL) Sees Mixed Analyst Actions as Zanzalintinib Nears Commercial Launch - Yahoo Finance

Click here to get full coverage on How The New Price Target Is Shaping The Exelixis (EXEL) Investment Story - Yahoo Finance

How The New Price Target Is Shaping The Exelixis (EXEL) Investment Story  Yahoo Finance

How The New Price Target Is Shaping The Exelixis (EXEL) Investment Story - Yahoo Finance

Click here to get full coverage on Why Is Exelixis (EXEL) Up 9% Since Last Earnings Report? - Yahoo Finance

Why Is Exelixis (EXEL) Up 9% Since Last Earnings Report?  Yahoo Finance

Why Is Exelixis (EXEL) Up 9% Since Last Earnings Report? - Yahoo Finance

Click here to get full coverage on Assessing Exelixis (EXEL) Valuation After Analysts Lift 2026 Earnings Forecasts - simplywall.st

Assessing Exelixis (EXEL) Valuation After Analysts Lift 2026 Earnings Forecasts  simplywall.st

Assessing Exelixis (EXEL) Valuation After Analysts Lift 2026 Earnings Forecasts - simplywall.st

Click here to get full coverage on Exel Composites plant in India begins volume shipments of carbon fiber wind energy components - CompositesWorld

Exel Composites plant in India begins volume shipments of carbon fiber wind energy components  CompositesWorld

Exel Composites plant in India begins volume shipments of carbon fiber wind energy components - CompositesWorld

Click here to get full coverage on UHC Faculty and Affiliates Featured in Latest Exel Magazine - Drexel

UHC Faculty and Affiliates Featured in Latest Exel Magazine  Drexel

UHC Faculty and Affiliates Featured in Latest Exel Magazine - Drexel

Click here to get full coverage on EXEL vs. EXAS: Which Stock Is the Better Value Option? - Yahoo Finance

EXEL vs. EXAS: Which Stock Is the Better Value Option?  Yahoo Finance

EXEL vs. EXAS: Which Stock Is the Better Value Option? - Yahoo Finance

Click here to get full coverage on Is It Too Late To Consider Exelixis (EXEL) After Strong Multi Year Share Gains? - Yahoo Finance

Is It Too Late To Consider Exelixis (EXEL) After Strong Multi Year Share Gains?  Yahoo Finance

Is It Too Late To Consider Exelixis (EXEL) After Strong Multi Year Share Gains? - Yahoo Finance

Click here to get full coverage on EXEL: Zanza and new indications drive growth, targeting $2.4B revenue and leadership in key oncology markets - TradingView

EXEL: Zanza and new indications drive growth, targeting $2.4B revenue and leadership in key oncology markets  TradingView

EXEL: Zanza and new indications drive growth, targeting $2.4B revenue and leadership in key oncology markets - TradingView

Click here to get full coverage on EXEL Industries: Total number of voting rights and shares at 02.28.2026 - Yahoo Finance

EXEL Industries: Total number of voting rights and shares at 02.28.2026  Yahoo Finance

EXEL Industries: Total number of voting rights and shares at 02.28.2026 - Yahoo Finance

Click here to get full coverage on Why Exelixis (EXEL) is Poised to Beat Earnings Estimates Again - Yahoo Finance

Why Exelixis (EXEL) is Poised to Beat Earnings Estimates Again  Yahoo Finance

Why Exelixis (EXEL) is Poised to Beat Earnings Estimates Again - Yahoo Finance

Click here to get full coverage on Exelixis (EXEL) CFO Christopher Senner awarded 52,018 RSU-based shares - Stock Titan

Exelixis (EXEL) CFO Christopher Senner awarded 52,018 RSU-based shares  Stock Titan

Exelixis (EXEL) CFO Christopher Senner awarded 52,018 RSU-based shares - Stock Titan

Click here to get full coverage on Exel Composites adopts bio-based UPR resin at commercial scale - CompositesWorld

Exel Composites adopts bio-based UPR resin at commercial scale  CompositesWorld

Exel Composites adopts bio-based UPR resin at commercial scale - CompositesWorld

Click here to get full coverage on EXEL Industries: Full-year 2024–2025 results - GlobeNewswire

EXEL Industries: Full-year 2024–2025 results  GlobeNewswire

EXEL Industries: Full-year 2024–2025 results - GlobeNewswire

Click here to get full coverage on EXEL: Zanzalintinib and CABOMETYX anchor growth in GI/GU oncology, with robust pipeline momentum - TradingView

EXEL: Zanzalintinib and CABOMETYX anchor growth in GI/GU oncology, with robust pipeline momentum  TradingView

EXEL: Zanzalintinib and CABOMETYX anchor growth in GI/GU oncology, with robust pipeline momentum - TradingView

Click here to get full coverage on $EXEL stock is down 13% today. Here's what we see in our data. - Quiver Quantitative

$EXEL stock is down 13% today. Here's what we see in our data.  Quiver Quantitative

$EXEL stock is down 13% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on EXEL Tops Q3 Earnings Estimates, Cabometyx Fuels Product Sales - Zacks Investment Research

EXEL Tops Q3 Earnings Estimates, Cabometyx Fuels Product Sales  Zacks Investment Research

EXEL Tops Q3 Earnings Estimates, Cabometyx Fuels Product Sales - Zacks Investment Research

Click here to get full coverage on How Recent Zanzalintinib Developments Are Reframing The Story For Exelixis (EXEL) - Yahoo Finance

How Recent Zanzalintinib Developments Are Reframing The Story For Exelixis (EXEL)  Yahoo Finance

How Recent Zanzalintinib Developments Are Reframing The Story For Exelixis (EXEL) - Yahoo Finance

Click here to get full coverage on Exelixis Inc (NASDAQ:EXEL) Emerges as a Compelling Value Investment Opportunity - ChartMill

Exelixis Inc (NASDAQ:EXEL) Emerges as a Compelling Value Investment Opportunity  ChartMill

Exelixis Inc (NASDAQ:EXEL) Emerges as a Compelling Value Investment Opportunity - ChartMill

Click here to get full coverage on Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report?  Yahoo Finance

Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Click here to get full coverage on Why Exelixis (EXEL) is One of the Best Healthcare Stocks Under $50 to Invest In - Yahoo Finance

Why Exelixis (EXEL) is One of the Best Healthcare Stocks Under $50 to Invest In  Yahoo Finance

Why Exelixis (EXEL) is One of the Best Healthcare Stocks Under $50 to Invest In - Yahoo Finance

Click here to get full coverage on Cancer drug maker Exelixis posts $2.3B 2025 sales, sets 2026 outlook - Stock Titan

Cancer drug maker Exelixis posts $2.3B 2025 sales, sets 2026 outlook  Stock Titan

Cancer drug maker Exelixis posts $2.3B 2025 sales, sets 2026 outlook - Stock Titan

Click here to get full coverage on EXEL SEC Filings - Exelixis Inc 10-K, 10-Q, 8-K Forms - Stock Titan

EXEL SEC Filings - Exelixis Inc 10-K, 10-Q, 8-K Forms  Stock Titan

EXEL SEC Filings - Exelixis Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Click here to get full coverage on Exelixis, Inc. (EXEL) Gets Upgraded to Outperform from Market Perform by Leerink Partners - Yahoo Finance

Exelixis, Inc. (EXEL) Gets Upgraded to Outperform from Market Perform by Leerink Partners  Yahoo Finance

Exelixis, Inc. (EXEL) Gets Upgraded to Outperform from Market Perform by Leerink Partners - Yahoo Finance

Click here to get full coverage on Ocean van Exel is a femme fashion maven - intomore.com

Ocean van Exel is a femme fashion maven  intomore.com

Ocean van Exel is a femme fashion maven - intomore.com

Click here to get full coverage on Exelixis, Inc. (EXEL): A Bull Case Theory - Yahoo Finance

Exelixis, Inc. (EXEL): A Bull Case Theory  Yahoo Finance

Exelixis, Inc. (EXEL): A Bull Case Theory - Yahoo Finance

Click here to get full coverage on EXELIXIS Q4 2025 Earnings Preview: Recent $EXEL Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

EXELIXIS Q4 2025 Earnings Preview: Recent $EXEL Insider Trading, Hedge Fund Activity, and More  Quiver Quantitative

EXELIXIS Q4 2025 Earnings Preview: Recent $EXEL Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

Click here to get full coverage on Exelixis (EXEL) Profit Margins Jump to 27%, Reinforcing Bullish Outlook on Accelerating Earnings - Yahoo Finance

Exelixis (EXEL) Profit Margins Jump to 27%, Reinforcing Bullish Outlook on Accelerating Earnings  Yahoo Finance

Exelixis (EXEL) Profit Margins Jump to 27%, Reinforcing Bullish Outlook on Accelerating Earnings - Yahoo Finance

Click here to get full coverage on Should Value Investors Buy Exelixis (EXEL) Stock? - Yahoo Finance

Should Value Investors Buy Exelixis (EXEL) Stock?  Yahoo Finance

Should Value Investors Buy Exelixis (EXEL) Stock? - Yahoo Finance

Click here to get full coverage on "It's a long time" - Nick Van Exel on his son getting a 60-year jail sentence for murder in 2013 - Yahoo Sports

"It's a long time" - Nick Van Exel on his son getting a 60-year jail sentence for murder in 2013  Yahoo Sports

"It's a long time" - Nick Van Exel on his son getting a 60-year jail sentence for murder in 2013 - Yahoo Sports

Click here to get full coverage on Morgan Stanley Maintains Overweight Rating For Exelixis, Inc. (EXEL), Price Target Raised To $50 - Yahoo Finance

Morgan Stanley Maintains Overweight Rating For Exelixis, Inc. (EXEL), Price Target Raised To $50  Yahoo Finance

Morgan Stanley Maintains Overweight Rating For Exelixis, Inc. (EXEL), Price Target Raised To $50 - Yahoo Finance

Click here to get full coverage on Insider Sale: EVP and CFO of $EXEL Sells 34,278 Shares - Quiver Quantitative

Insider Sale: EVP and CFO of $EXEL Sells 34,278 Shares  Quiver Quantitative

Insider Sale: EVP and CFO of $EXEL Sells 34,278 Shares - Quiver Quantitative

Click here to get full coverage on A Dive into Exelixis (EXEL) International Revenue Trends and Forecasts - Yahoo Finance

A Dive into Exelixis (EXEL) International Revenue Trends and Forecasts  Yahoo Finance

A Dive into Exelixis (EXEL) International Revenue Trends and Forecasts - Yahoo Finance

Click here to get full coverage on Here's Why Exelixis (EXEL) is a Strong Value Stock - Yahoo Finance

Here's Why Exelixis (EXEL) is a Strong Value Stock  Yahoo Finance

Here's Why Exelixis (EXEL) is a Strong Value Stock - Yahoo Finance

Click here to get full coverage on NBA all-star's former Houston party mansion to be sold to the highest bidder - Chron

NBA all-star's former Houston party mansion to be sold to the highest bidder  Chron

NBA all-star's former Houston party mansion to be sold to the highest bidder - Chron

Click here to get full coverage on Assessing Exelixis (EXEL) Valuation After Recent Share Price Volatility - Yahoo Finance

Assessing Exelixis (EXEL) Valuation After Recent Share Price Volatility  Yahoo Finance

Assessing Exelixis (EXEL) Valuation After Recent Share Price Volatility - Yahoo Finance

Click here to get full coverage on “That was the best year of my basketball life ever” – Nick Van Exel on Cincinnati’s unforgettable 1992 Final Four run - Basketball Network

“That was the best year of my basketball life ever” – Nick Van Exel on Cincinnati’s unforgettable 1992 Final Four run  Basketball Network

“That was the best year of my basketball life ever” – Nick Van Exel on Cincinnati’s unforgettable 1992 Final Four run - Basketball Network

Click here to get full coverage on Insider Sale: Director at $EXEL Sells 100,000 Shares - Quiver Quantitative

Insider Sale: Director at $EXEL Sells 100,000 Shares  Quiver Quantitative

Insider Sale: Director at $EXEL Sells 100,000 Shares - Quiver Quantitative

Click here to get full coverage on Exelixis (NASDAQ: EXEL) announces $750M buyback and reports Q3 revenue of $598M - Stock Titan

Exelixis (NASDAQ: EXEL) announces $750M buyback and reports Q3 revenue of $598M  Stock Titan

Exelixis (NASDAQ: EXEL) announces $750M buyback and reports Q3 revenue of $598M - Stock Titan

Click here to get full coverage on Exelixis Stock Likely To Go Higher On A Possible Key FDA Approval (NASDAQ:EXEL) - Seeking Alpha

Exelixis Stock Likely To Go Higher On A Possible Key FDA Approval (NASDAQ:EXEL)  Seeking Alpha

Exelixis Stock Likely To Go Higher On A Possible Key FDA Approval (NASDAQ:EXEL) - Seeking Alpha

Click here to get full coverage on 3 Reasons Why Growth Investors Shouldn't Overlook Exelixis (EXEL) - Yahoo Finance

3 Reasons Why Growth Investors Shouldn't Overlook Exelixis (EXEL)  Yahoo Finance

3 Reasons Why Growth Investors Shouldn't Overlook Exelixis (EXEL) - Yahoo Finance

Click here to get full coverage on Exelixis Inc (EXEL) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

Exelixis Inc (EXEL) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...  Yahoo Finance

Exelixis Inc (EXEL) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

Click here to get full coverage on EXEL Industries: Total number of voting rights and shares at 02.28.2026 - GlobeNewswire

EXEL Industries: Total number of voting rights and shares at 02.28.2026  GlobeNewswire

EXEL Industries: Total number of voting rights and shares at 02.28.2026 - GlobeNewswire

Click here to get full coverage on EXEL Industries: Q1 2025–2026 revenue -17.5% - Yahoo Finance

EXEL Industries: Q1 2025–2026 revenue -17.5%  Yahoo Finance

EXEL Industries: Q1 2025–2026 revenue -17.5% - Yahoo Finance

Click here to get full coverage on Exelixis: High-Growth Oncology Name Trading At A Discount (NASDAQ:EXEL) - Seeking Alpha

Exelixis: High-Growth Oncology Name Trading At A Discount (NASDAQ:EXEL)  Seeking Alpha

Exelixis: High-Growth Oncology Name Trading At A Discount (NASDAQ:EXEL) - Seeking Alpha

Click here to get full coverage on Exelixis Inc (EXEL) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Challenges - Yahoo Finance

Exelixis Inc (EXEL) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Challenges  Yahoo Finance

Exelixis Inc (EXEL) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Challenges - Yahoo Finance

Click here to get full coverage on Exelixis (EXEL) Tumbles 16.8% as Q2 Earnings Disappoint - Yahoo Finance

Exelixis (EXEL) Tumbles 16.8% as Q2 Earnings Disappoint  Yahoo Finance

Exelixis (EXEL) Tumbles 16.8% as Q2 Earnings Disappoint - Yahoo Finance

Click here to get full coverage on Exelixis (EXEL): Evaluating Valuation After Phase 3 Study Halt, Revenue Miss, and Legal Investigation News - simplywall.st

Exelixis (EXEL): Evaluating Valuation After Phase 3 Study Halt, Revenue Miss, and Legal Investigation News  simplywall.st

Exelixis (EXEL): Evaluating Valuation After Phase 3 Study Halt, Revenue Miss, and Legal Investigation News - simplywall.st

Click here to get full coverage on Is Exelixis (EXEL) Using Zanzalintinib To Redefine Its Post-Cabometyx Oncology Strategy? - Yahoo Finance

Is Exelixis (EXEL) Using Zanzalintinib To Redefine Its Post-Cabometyx Oncology Strategy?  Yahoo Finance

Is Exelixis (EXEL) Using Zanzalintinib To Redefine Its Post-Cabometyx Oncology Strategy? - Yahoo Finance

Click here to get full coverage on Exelixis (EXEL) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance

Exelixis (EXEL) Reports Next Week: Wall Street Expects Earnings Growth  Yahoo Finance

Exelixis (EXEL) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance

Click here to get full coverage on Colorectal cancer drug combo that cut death risk now under FDA review - Stock Titan

Colorectal cancer drug combo that cut death risk now under FDA review  Stock Titan

Colorectal cancer drug combo that cut death risk now under FDA review - Stock Titan

Click here to get full coverage on Exel Composites signs €25 million multi-year agreement with De Angeli Prodotti - jeccomposites.com

Exel Composites signs €25 million multi-year agreement with De Angeli Prodotti  jeccomposites.com

EXEL

Price Chart

Key Statistics

Technicals

About EXEL

Latest News

RBC Capital lowers Exelixis (EXEL) price target to $43 - MSN

Exel Composites Reduces Shares Quantity, Changes ISIN and Trading Code - TradingView

EXEL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Advanced Charts

Top Gainers

Top Losers